1. |
Sobin LH, Gospodarowicz MK, Wittekind C. International Union Against Cancer (UICC) TNM classification of malignant tumours. 7th ed. New York:Wiley-Liss, 2010:117-126.
|
2. |
李国立, 范朝刚, 鲍扬, 等.动静脉结合给药的FLEEOX方案对以淋巴结转移为主晚期胃癌的新辅助化疗.中华外科杂志, 2009, 47(15):1171-1174.
|
3. |
Iida T, Hirata N, Hirakawa M, et al. Preoperative intraarterial infusion chemotherapy for advanced gastric cancer-a retrospective review of four cases. Radiat Med, 2003, 21(4):172-177.
|
4. |
Nakajima T. Gastric cancer treatment guidelines in Japan. Gastric Cancer, 2002, 5(1):1-5.
|
5. |
Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst, 2000, 92(3):205-216.
|
6. |
Trotti A, Bentzen SM. The need for adverse effects reporting standards in oncology clinical trials. J Clin Oncol, 2004, 22(1):19-22.
|
7. |
李国立, 刘坤, 王绪林, 等.胃癌术前化疗的疗效评价.中国普外基础与临床杂志, 2012, 19(1):12-15.
|
8. |
Wilke H, Preusser P, Fink U, et al. Preoperative chemotherapy in locally advanced and nonresectable gastric cancer:a phase Ⅱ study with etoposide, doxombicin, and cisplatin. J Clin Oncol, 1989, 7(9):1318-1326.
|
9. |
李子禹, 季鑫, 季加孚.新辅助化疗对胃癌手术并发症的影响.中国实用外科杂志, 2013, 33(4):275-278.
|
10. |
季加孚, 武爱文.进展期胃癌的新辅助化疗.中华胃肠外科杂志, 2008, 11(2):110-111.
|
11. |
Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med, 2006, 355(1):11-20.
|
12. |
Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med, 2007, 357(18):1810-1820.
|
13. |
Yamanaka T, Matsumoto S, Teramukai S, et al. Safety evaluation of oral fluoropyrimidine S-1 for shortand long-term delivery in advanced gastric cancer:analysis of 3 758 patients. Cancer Chemother Pharmacol, 2008, 61(2):335-343.
|
14. |
Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC):a phase 3 open-label, randomised controlled trial. Lancet, 2012, 379(9813):315-321.
|
15. |
陆文, 刘燕, 邵丽华, 等.奥沙利铂联合卡培他滨新辅助化疗治疗进展期胃癌的临床观察.实用医学杂志, 2011, 27(2):295-297.
|
16. |
Nakajima T, Ota K, Ishiham s, et al. Combined intensive chemotherapy and radical surgery for incurable gastric cancer. Ann Surg Oncol, 1997, 4(3): 203-208.
|
17. |
李国立, 鲍阳, 姜军, 等.动静脉联合给药的FLEOX新辅助化疗加营养支持提高晚期胃癌可切除率.中华胃肠外科杂志, 2008, 11(5):428-431.
|
18. |
Zhang C, Li G, Fan C, et al. Comparison of efficacy of different route of administration of chemotherapy on unresectable, advanced gastric cancer. World J Surg Oncol, 2012, 10:162-170.
|
19. |
甘建春, 刘宁, 王德侯, 等.血清肿瘤标志物CEA、CA19-9及CA72-4在胃癌中的应用价值研究.中华全科医学, 2014, 12(6):882-884, 919.
|
20. |
顾金花, 顾涛, 周丽娜, 等.血清VEGF、CEA、CA19-9和SF水平变化在晚期胃癌患者化疗疗效评估中的价值.国际检验医学杂志, 2014, 35(18):2459-2461.
|
21. |
苏向前, 杨宏, 邢加迪, 等.腹腔镜胃癌外科的发展现状与思考.中华胃肠外科杂志, 2012, 15(8):773-775.
|
22. |
陈红兵, 张寿儒, 何敬萍, 等.腹腔镜辅助胃癌D2根治术的临床研究.中国微创外科杂志, 2014, 14(2):112-114.
|
23. |
余佩武, 钱锋, 郝迎学, 等.腹腔镜胃癌根治术726例的疗效分析.中华消化外科杂志, 2011, 10(1):44-47.
|
24. |
中华医学会外科分会腹腔镜与内镜外科学组.腹腔镜胃癌手术操作指南(2007年版).中华消化外科杂志, 2007, 6(6):476-480.
|
25. |
余佩武.腹腔镜胃癌手术的进展与展望.中国普外基础与临床杂志, 2011, 18(2):105-109.
|
26. |
Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration:pathophysiologic effects and clinical implications. J Am Coll Surg, 2002, 195(5):694-712.
|
27. |
周琏, 杨坤兴, 吕成余, 等.围手术期应用糖皮质激素对胃癌患者术后康复的影响.江苏医药, 2009, 35(5):529-530, 560.
|
28. |
吴梅青, 周旭坤, 李平, 等.新辅助化疗联合腹腔镜辅助D2近端胃癌根治术治疗近端进展期胃癌.中国微创外科杂志, 2014, 14(2):109-111.
|